Cristina Gasparetto, MD Cristina Gasparetto, MD

Cristina Gasparetto, MD

Cell Therapy and Hematologic Malignancies Specialist

4.9 out of 5  (237 ratings, 29 reviews)
Duke Health Provider question Circle Img
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Below are the plans currently accepted in 2018. There are some changes to the plans accepted beginning January 1, 2019. More information will become available on PlanForDuke.com.

Click to see a list of accepted insurance plansHide accepted insurance plans
Contact
919-668-1091
Fax number
919-668-1027 Appointments
919-668-1091 Fax number
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Below are the plans currently accepted in 2018. There are some changes to the plans accepted beginning January 1, 2019. More information will become available on PlanForDuke.com.

Click to see a list of accepted insurance plansHide accepted insurance plans

Contact
919-668-1091 Fax number
WHERE I PROVIDE CARE
Profile
ABOUT ME

The Division of Cellular Therapy does bone marrow transplants and stem cell transplants for patients with different types of blood cancers. Specifically, I see patients with multiple myeloma or other plasma cell issues like amyloidosis. Many of the cases in my clinic are difficult. So I spend a lot of time talking with my patients, explaining the disease when they come as new patients and talking about the complexity of the disease, because it’s important that they understand what to ask their physicians here at Duke and at home. There’s no standard treatment for myeloma. We have different options – continuation of therapy, immediate transplant or transplant later. I like to explain to patients why I favor a certain treatment approach and why I think it would be the best approach for them.

LANGUAGES I SPEAK
English, Italian
LEARN MORE ABOUT ME
Training
EDUCATION
MD, Sapienza University of Rome (Italy), 1986
RESIDENCY
Internal Medicine, Duke University Medical Center, 1993-1996
Hematology and Bone Marrow Transplant, Duke University Medical Center, 1996-1999
Clinical Focus and Research
MY RESEARCH INTERESTS

My work focuses on clinical translational research in multiple myeloma and other plasma cell disorders such as AL amyloidosis, Waldenstrom’s disease. As Director of the Multiple Myeloma Program at Duke, I lead studies in both the transplant and non transplant settings for these diseases, evaluating new drugs developed for patients. I have co-authored investigations on novel targeted therapies used alone and/or in combination for multiple myeloma and amyloidosis. Current work focuses on expanding allogeneic immunotherapy for high risk patients with multiple myeloma of plasma cell leukemia.

Ratings and Reviews

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more about our survey process. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Overall provider rating
4.9 out of 5 (237 ratings, 29 reviews)
PATIENT REVIEWS
Patient comments are gathered from our Press Ganey Patient Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
Industry Relationships and Collaborations
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
  • Axess Oncology
  • Celgene Corporation
  • Millennium Pharmaceuticals, Inc. (Takeda)
  • Novartis
  • Onyx/Amgen